Blast Phase
1 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Homoharringtonine With Oral Gleevec in Chronic, Accelerated and Blast Phase Chronic Myeloid Leukemia (CML) (NCT00114959) | ChemGenex Pharmaceuticals | 2005-10-01 |
Track Blast Phase automatically
Every clearance here is in the API, with alerts when new ones post.